Shopping Cart
- Remove All
- Your shopping cart is currently empty
Alvespimycin (17-DMAG) is a potent Hsp90 inhibitor that binds to Hsp90, exhibiting potential anticancer activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | 84 € | In Stock | |
10 mg | 135 € | In Stock | |
25 mg | 274 € | In Stock | |
50 mg | 406 € | In Stock | |
100 mg | 591 € | In Stock |
Description | Alvespimycin (17-DMAG) is a potent Hsp90 inhibitor that binds to Hsp90, exhibiting potential anticancer activity. |
Targets&IC50 | HSP90:62 nM (EC50), GRP94:65 nM (EC50) |
In vitro | After treatment with vehicle control or 1 μM Alvespimycin (17-DMAG) for 24 hours, CLL patient cells showed that Alvespimycin downregulated NF-κB signaling through IKKα and IKKβ[2]. |
In vivo | Treatment with vehicle (DMSO) or Alvespimycin(17-DMAG)(10 mg/kg) significantly prolonged the survival time of TCL1-SCID model mice[2]. |
Alias | KOS-1022, KOS1022, KOS 1022, 17-DMAG |
Molecular Weight | 616.75 |
Formula | C32H48N4O8 |
Cas No. | 467214-20-6 |
Smiles | CO[C@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O |
Relative Density. | 1.2 |
Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (129.71 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.